Are you Dr. Prosser?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3401 N Broad St
Temple University Hospital
Philadelphia, PA 19140Phone+1 215-707-5030Fax+1 215-707-3494
Summary
- Dr. Jane Prosser, MD is a board certified emergency medicine physician in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, California, and New York. She is affiliated with Kaiser Permanente Vallejo Medical Center and is an Assistant Professor at Weill Cornell Medical College.
Education & Training
- NYU Grossman School of MedicineFellowship, Medical Toxicology (Emergency Medicine), 2007 - 2009
- University of Pennsylvania Health SystemResidency, Emergency Medicine, 2002 - 2006
- Lewis Katz School of Medicine at Temple UniversityClass of 2002
Certifications & Licensure
- CA State Medical License 2016 - 2025
- NY State Medical License 2007 - 2016
- PA State Medical License 2002 - 2008
- American Board of Emergency Medicine Emergency Medicine
- American Board of Emergency Medicine Medical Toxicology
Publications & Presentations
PubMed
- 13 citationsImpact of Mandatory Carbon Monoxide Alarms: An Investigation of the Effects on Detection and Poisoning Rates in New York CityKatherine Wheeler-Martin, Sari Soghoian, Jane M. Prosser, Alex F. Manini, Elizabeth Marker
American Journal of Public Health. 2015-07-09 - 6 citationsNegative Predictive Value of Acetaminophen Concentrations Within Four Hours of IngestionBlake A. Froberg, Kerry J. King, Theomal D. Kurera, Andrew A. Monte, Jane M. Prosser
Academic Emergency Medicine. 2013-10-01 - 422 citationsThe Toxicology of Bath Salts: A Review of Synthetic CathinonesJane M. Prosser, Lewis S. Nelson
Journal of Medical Toxicology. 2012-03-01
Press Mentions
- Migraine-Targeting Drug Approved for Aussie UseAugust 22nd, 2018